News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,311 Results
Type
Article (13670)
Company Profile (100)
Press Release (249541)
Section
Business (88047)
Career Advice (464)
Deals (15346)
Drug Delivery (64)
Drug Development (36590)
Employer Resources (49)
FDA (6272)
Job Trends (6195)
News (150196)
Policy (14021)
Tag
Academia (437)
Alliances (23209)
Alzheimer's disease (373)
Approvals (6282)
Artificial intelligence (82)
Bankruptcy (144)
Best Places to Work (4364)
Breast cancer (66)
Cancer (467)
Cardiovascular disease (48)
Career advice (406)
Cell therapy (65)
Clinical research (30676)
Collaboration (252)
Compensation (97)
COVID-19 (756)
C-suite (81)
Data (461)
Diabetes (64)
Diagnostics (1270)
Drug discovery (45)
Drug pricing (59)
Earnings (31692)
Events (37099)
Executive appointments (281)
FDA (6549)
Funding (161)
Gene therapy (74)
GLP-1 (315)
Government (1275)
Healthcare (3561)
Infectious disease (778)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5862)
Job creations (2050)
Job search strategy (372)
Layoffs (172)
Legal (3422)
Lung cancer (66)
Manufacturing (116)
Medical device (1271)
Medtech (1273)
Mergers & acquisitions (9600)
Metabolic disorders (201)
Neuroscience (505)
NextGen: Class of 2025 (1583)
Non-profit (597)
Northern California (562)
Obesity (120)
Opinion (114)
Patents (71)
People (28687)
Pharmaceutical (63)
Phase I (7994)
Phase II (12974)
Phase III (11646)
Pipeline (242)
Policy (48)
Postmarket research (1401)
Preclinical (3195)
Radiopharmaceuticals (117)
Rare diseases (123)
Real estate (2632)
Regulatory (9947)
Research institute (563)
Resumes & cover letters (55)
Southern California (549)
Startups (1626)
United States (5531)
Vaccines (127)
Weight loss (86)
Date
Today (70)
Last 7 days (241)
Last 30 days (975)
Last 365 days (12429)
2025 (975)
2024 (12533)
2023 (14284)
2022 (19595)
2021 (20097)
2020 (19064)
2019 (14892)
2018 (11719)
2017 (13892)
2016 (13132)
2015 (15476)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10889)
Location
Africa (312)
Arizona (46)
Asia (19979)
Australia (2581)
California (1323)
Canada (735)
China (172)
Colorado (52)
Connecticut (54)
Europe (39119)
Florida (228)
Illinois (149)
Indiana (106)
Japan (62)
Kansas (53)
Maryland (196)
Massachusetts (1160)
Minnesota (72)
New Jersey (554)
New York (373)
North Carolina (321)
Northern California (562)
Pennsylvania (344)
South America (500)
Southern California (549)
Texas (171)
Virginia (51)
Washington State (87)
263,311 Results for "adare pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist
December 11, 2024
·
6 min read
Press Releases
Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
October 10, 2024
·
2 min read
Business
Covant Therapeutics Debuts with Boehringer Partnership Targeting ADAR1
Boston-based Covant Therapeutics gained $10 million upfront in a deal with Boehringer Ingelheim to chase after a cancer immunotherapy target, ADAR1.
March 29, 2023
·
3 min read
·
Ana Mulero
Genetown
Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients
Covant Therapeutics, an innovative covalent drug discovery company, has entered into an exclusive research collaboration and worldwide licensing agreement with Boehringer Ingelheim covering Covant’s ADAR1 program.
March 28, 2023
·
2 min read
Genetown
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it has successfully defended against two oppositions that were filed against a key patent for its ADAR-mediated RNA editing platform Axiomer®.
March 14, 2023
·
5 min read
Genetown
ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing
ProQR Therapeutics N.V. announced it has further strengthened its leading intellectual property estate with the issuance of a new patent in the United States and that it has successfully defended against an opposition to its IP in Japan.
November 6, 2023
·
5 min read
Policy
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
ProQR Therapeutics N.V. today announced it has again successfully defended against opposition filed against a key patent for its ADAR-mediated RNA editing platform Axiomer™.
April 19, 2024
·
5 min read
Business
Adare Pharma Solutions Appoints Ludger Roedder as President, Adare Biome
Adare Pharma Solutions is excited to announce that Ludger Roedder has joined the organization as President of Adare Biome.
April 20, 2021
·
3 min read
Deals
Adare Pharma Solutions Acquires Frontida BioPharm to Expand Leading CDMO Offerings
Adare Pharma Solutions, a technology-driven contract development and manufacturing organization, announced the acquisition of Frontida BioPharm, a vertically integrated CDMO focused on oral formulations.
December 1, 2021
·
2 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
1 of 26,332
Next
